Skip to main content
. 2021 Mar 16;12:652846. doi: 10.3389/fimmu.2021.652846

Table 1.

IL-1 family antagonist expression, activity, and signaling.

Cytokine Producing cell Target cell Receptor Effect
IL-1Ra Keratinocytes (89, 90, 94, 98101)
Infiltrating myeloid cells (89, 94)
Keratinocytes
Fibroblasts
Myeloid cells
IL-1R1 Inhibition of IL-1 activity (94, 102, 111)
IL-36Ra Keratinocytes (103, 114118)
Myeloid cells (114, 115, 119, 120)
Keratinocytes
Myeloid cells
CD4+ T cells
IL-36R Inhibition of IL-36 activity (121124)
IL-37 Keratinocytes (103, 125127) Myeloid cells IL-18Rα Broad inhibition of pro-inflammatory signaling (128132)
IL-18RAP Inhibition of IL-18 activity (133)
IL-38 Keratinocytes (103, 117, 118, 124, 134136) γδ T cells TIGIRR-2 Inhibition of IL-17A production (135)
Myeloid cells TIGIRR-2
IL-36R?
Broad anti-inflammatory activity (50, 137)
Keratinocytes IL-36R? Inhibition of IL-36γ activity (124)

For each antagonist, the main producing cell type(s), target cells, receptors, and effects relevant to skin biology are listed. A comprehensive description of biological effects reported for each cytokine can be found in the text.